Overview of Polio Legacy Transition Planning

Slides:



Advertisements
Similar presentations
1 Agenda item 4: Work modalities of the revised ISDR system to support the implementation of Hyogo Framework- Elements to be reviewed in groups- & prepare.
Advertisements

The Work of WHO in the South-East Asia Region Member countries made steady progress in health development Health development WHO focused on country.
A global partnership to stop measles & rubella The Measles & Rubella Initiative: Preparing for the Next Decade Lisa Cairns, MD, MPH Sept 18, 2012 Washington,
Comprehensive M&E Systems
Global Measles and Rubella Management Meeting Progress and Challenges in Bangladesh March, 2011 Geneva, WHO HQ Dr Serguei Diorditsa.
A Comprehensive Policy framework for the National Immunization Programme Dr Nihal Abeysinghe, [M.B.,B.S., MSc, M.D.] Chief Epidemiologist, Ministry of.
STRENGTHENING the AFRICA ENVIRONMENT INFORMATION NETWORK An AMCEN initiative A framework to support development planning processes and increase access.
Cross Border Animal Health Plan of Action – Kenya and Uganda Four Strategic areas 1. To improve prevention, management and control of cross border animal.
Reaching the 2010 Measles Mortality Reduction Goal-can SEARO get there? Meeting of the Partners for Measles Advocacy Washington DC, September 2008.
REGIONAL ANALYSIS ON DISASTER RISK REDUCTION EDUCATION IN THE ASIA PACIFIC REGION IN THE CONTEXT OF HFA PRIORITY 3 IMPLEMENTATION Bangkok, March 2009 Prepared.
Outline Background Objectives and activities GPEI assets
Report on the Evaluation Function Evaluation Office.
Multi-Year Plans Strengthening immunization systems and introduction of hepatitis B vaccine in Central Europe and the Newly Independent States St. Petersburg,
1 Progress Towards Polio Eradication in EMR. 2 Status of global eradication Priority countries (except EMR) : Intensification : Certification,
Plan for Phase V of the Malé Declaration ( ) The Secretariat.
Africa Health Workforce Platform & Observatory Presentation to the 1st conference of the Asia-Pacific Action Alliance on HRH (AAAH): October 2006.
JAHSR TECHNICAL REVIEW MEETING EPI Report Dr Dafrossa C Lyimo Programme Manager 7th September 2010 Dar es salaam.
1 1 Bose: SEAR Highlights and Priorities Global Measles & Rubella Management Meeting Geneva, March 2011 Accelerated Measles Control: Highlights and.
Tracking national portfolios and assessing results Sub-regional Workshop for GEF Focal Points in West and Central Africa June 2008, Douala, Cameroon.
WHO EURO In Country Coordination and Strengthening National Interagency Coordinating Committees.
India: Transitioning of Polio Network to Support Other Immunization Activities Jeffrey W McFarland, MD Regional Advisor, WHO South-East Asia Regional Office.
Making Lab network sustainable after Polio Presenter: Varavikova Elena, MD, PhD, MPH.
Consultant Advance Research Team. Outline UNDERSTANDING M&E DATA NEEDS PEOPLE, PARTNERSHIP AND PLANNING 1.Organizational structures with HIV M&E functions.
The implementation programme for the 2008 SNA and supporting statistics UNECE special session on National Accounts for economies in transition Geneva,
Sudan EPI Benefits From Polio Eradication Program M&RI Annual Partners Meetings Washington D.C September 2015 Sudan EPI Benefits From Polio Eradication.
Update on Progress toward Measles Situation in EMR September 2008 Dr B. Naouri VPI/DCD/EMRO.
Human resources for maternal, newborn and child health: opportunities and constraints in the Countdown priority countries Neeru Gupta Health Workforce.
Global Partnership for Enhanced Social Accountability (GPESA) December 19, 2011 World Bank.
Comprehensive M&E Systems: Identifying Resources to Support M&E Plans for National TB Programs Lisa V. Adams, MD E&E Regional Workshop Kiev, Ukraine May.
2015 Measles & Rubella Initiative Annual Partners Meeting, Human & Financial Costs of Measles and Rubella, 15 September 2015, Washington, DC Achieving.
A global partnership to stop measles & rubella 1 Measles & Rubella Initiative --Who We Are-- Stephen Cochi, MD, MPH Global Immunization Division Centers.
February 2015 An introduction to the switch from trivalent to bivalent oral polio vaccines 1.
Measles and Rubella Initiative Financial Resource Requirements for Measles and Rubella Annual Partners Meeting, September
Support to Strengthening Devolved Structures’ Capacity for Emergency Preparedness and Response (EPR) 12 th October 2016 The 4 th National Symposium on.
Important terminology
Census Planning and Management for next Nigerian Census
Vaccine-Preventable Disease Surveillance: Why is it important?
Social Protection Global Technical Team Retreat,
Launched March at UN Statistical Commission in side event
Framework for Getting Results at Scale
Roadmap for Health in All Policies in Sudan
Session 4 Cross Cutting MR and RI Priorities Introduction
Sendai Framework for Disaster Risk Reduction
Discussion of CRVS strategies
Review of integrated PSM resources and tools and introduction to group work Upjeet Chandan ICCM FTT 17th February 2016.
9/16/2018 The ACT Government’s commitment to Performance and Accountability – the role of Evaluation Presentation to the Canberra Evaluation Forum Thursday,
Measles & Rubella Initiative Partners meeting September 7-8, 2017
POLIOPLUS FACT SHEET Feb 2018
National health policy review
GIFT and IBP Pilot PROJECT on PUBLIC PARTICIPATION
UK role in Statistical Capacity Building
Sustainable Transition / Handover of malaria TB and HIV Global Fund Grants Generic 2018.
Integrated DRR and CCA Mainstreaming TOOL OUTLINE
SRH & HIV Linkages Agenda
WHO Global Influenza Programme
High level seminar on the implementation of the
How do we progress the multi-sectoral nutrition agenda in Sudan?
Health system assessments
Action Points 6 November 2007 Cape Town, South Africa
Building Statistical Capacity UNSD perspective
24 January 2018 Juba, Republic of South Sudan
Caribbean Community Secretariat
State of Measles Initiative Financing Partners for Measles Advocacy Meeting Washington, D.C. September 22, 2008 Andrea Gay.
Millennium Development Goals (MDGs)
Partners for Measles Advocacy—7th Annual Meeting
YELLOW FEVER VACCINE AVAILABILITY AND NEEDS FOR THE AFRICAN REGION
Comprehensive M&E Systems
Draft revision of ISPM 6: National surveillance systems ( )
A year of progress on global and country coordination on PHC
Notes: Rapid assessments.
Presentation transcript:

Overview of Polio Legacy Transition Planning Stephen Cochi, MD, MPH Polio Legacy Management Group, GPEI India Expert Advisory Group Meeting on Polio Eradication 20 March 2015

Polio Endgame Strategic Plan 2013-18 Objective 1 Polio virus detection and interruption Objective 2 Immunization systems strengthening and OPV withdrawal Objective 3 Containment and certification Objective 4 Legacy planning “…ensure that the investments made to eradicate poliomyelitis contribute to future health goals, through a programme of work to systematically document and transition the knowledge, lessons learned and assets of the Global Polio Eradication Initiative… establishment of a comprehensive polio legacy strategic plan by no later than end-2015.”

Legacy Planning: Main Elements What is Polio Legacy Planning? Legacy Planning: Main Elements Mainstream Essential Polio Functions Define needs up to eradication and beyond Develop plans at country/global level Capture & Disseminate Lessons Learned Through Stakeholder Consultations Documentation and Dissemination mechanisms Map polio program assets & capabilities Transition of capacities, processes, assets Develop Global Legacy Framework Support Development of Regional/Country/Agency Legacy Plans

Lessons Learned: Objectives Legacy Planning: Lessons Learned Lessons Learned: Objectives Document the lessons learned and knowledge generated through >25 years of polio eradication. Ensure that the lessons learned and knowledge generated are shared with other health initiatives. Document how polio infrastructure is currently contributing to other immunization/public health priorities (so-called “Legacy in Action”) Each country has unique circumstances and experiences, and would benefit from doing its own “Lessons Learned” documentation exercise

Global Progress in Legacy Planning Development of an ‘Evidence Base’ Capabilities, Functions, Assets & Contributions to other priorities Pilot Planning Studies conducted in DRC & Nepal To learn how transition planning could work in different settings Draft Transition Guidelines To guide countries in the development of legacy transition plans Draft Global Framework to WHA Outlines proposed phased approach to legacy planning Polio Partners Group Legacy Workshop – October 2014 Guidance on direction and content

Estimated time allocation of polio-funded workers by country Survey of country-level polio program managers in 5 countries shows significant time spent supporting other health priorities Estimated time allocation of polio-funded workers by country 100% 5% 3% 1% 5% 0% 5% 1% 4% 3% 5% 4% 3% 1% 1% 7% 5% 6% 2% 0% 2% 1% 6% 3% 2% 1% 2% 2% 9% 4% 1% 3% 1% 1% 3% 2% 0% 1% 0% 4% 1% 1% 75% 4% 18% 28% 19% 26% 23% 28% 11% 50% 20% 11% 12% 14% 21% 25% 54% 44% 39% 42% 43% 31% 0% DRC Nepal India Ethiopia Somalia Overall Polio New vaccine introduction MNCH & nutrition Other diseases & programs Measles & rubella Child health days/weeks Health systems strengthening Routine immunization Sanitation & hygiene Natural disasters & crises 1.Eligible population excludes assistants, secretaries, drivers, clerks, back office support (e.g. HR, finance, IT), and Rotary volunteers Source: Polio Legacy Survey

GPEI program personnel are focused in endemic countries and transitioning countries Endemic country Current/ recent outbreak (2013-2014) Transition (last case 2011-2012) Mid-term polio free (last case 2001-2010) Long term polio free (last case 2000 or before) No GPEI personnel present Headcount 16,982 17,000 10,447 996 500 407 258 Endemic Recent outbreakRecent outbreak Transition Mid-term freeMid-term free Long-term freeLong-term free Source: GPEI Partner databases

Pilot case study In Nepal, polio-funded IPD division is backbone of surveillance activities and only surveillance for VPDs Immunization Preventable Disease (IPD) program provides surveillance IPD 's network is an integral part of Nepal's public health system IPD represents WHO polio program in Nepal, and is focused mainly on surveillance 15 surveillance officers, 6 technical officers, and 36 support staff Originally focused on AFP surveillance, but expanded purview in 2003 to include other diseases (which are still monitored today) AFP Measles and rubella like cases Acute encephalitis syndrome for Japanese encephalitis Neonatal tetanus IPD is a critical part of the surveillance and data systems in Nepal EWARS: Early warning and reporting system tracks vector borne diseases like malaria and dengue through passive surveillance HMIS: Health Management & Information System (part of government) collects health data from different surveillance networks and hospital sites IPD: Immunization Preventable Disease program provides tracking of vaccine preventable diseases via passive surveillance, active monitoring, and case investigation Without IPD, it is likely the coverage of VPDs in Nepal would significantly degrade "Without IPD, without the SMOs, surveillance would just go away in Nepal" - Government of Nepal official

India--Support other priority health areas Routine immunization Key thematic areas for engagement of polio workforce to support RI identified Measles elimination and Rubella control by 2020 Support provided for expansion of lab based MR surveillance in 25 states Support provided for measles campaigns Intensified RI monitoring Capacity building of frontline workers Advocacy & Integrated communication Tagging of HRAs to RI session sites Accountability through Task Forces Laboratory Based Measles/Rubella Surveillance Expansion - India Information from polio microplans used for inclusion of left out areas in RI Functioning (25 states) To be initiated (7 states\UTs) In process (3 state\UTs)

Legacy Implementation – Major Themes National Level Planning: Tailoring approach to country context & linking with existing plans Roles for donors, civil society, stakeholders in the process Global & Regional Priorities: Resources for immunization, VPD surveillance, emergency response Planning & Sequencing To avoid disruption to both polio eradication & core services Sequencing priority countries Cost of legacy planning: Costs of transition planning; sources of funding Maintenance of Essential Polio Functions: Requires separate planning and budgeting

Potential transition timing: Must link with broader organizational timelines for polio asset support RELATIVE TIMELINE - PROPOSED Phase of Transition Planning & Decision Preparation Execution Execution Country transition plan finalized and agreed upon Transition process initiated Outcome Assets ready for transition (e.g., funding available, initial trainings conducted) Assets fully operational in new roles (depending on nature of transition) Estimated Timeline 12 months Within 6 months of decision Within 12 months of plan in place 2-5 years after plan in place ABSOLUTE TIMELINE - INDICATIVE 2014 2015 2016 2017 2018 2019 Global Eradication Certification Stakeholder engagement needed to raise awareness of need for country-level planning Phase Country examples WHA RCMs Transition planning underway DRC Nepal India Planning & Decision Preparation & Execution All other polio-free and recent outbreak Sudan Bangladesh Ethiopia Indonesia Somalia Myanmar S. Sudan Egypt Angola Chad Planning & Decision Preparation & Execution Legacy transition phase Timeline contingent upon eradication status Current endemics Nigeria Pakistan Afghanistan Planning & Decision Preparation & Execution Timeline contingent upon eradication status

Legacy Planning: Overall, what would a successful outcome look like? Legacy Planning: Outcome Legacy Planning: Overall, what would a successful outcome look like? Well-planned and managed conclusion of the GPEI – (post- certification) with liabilities and disruption to staff and the programme minimized (HR/Legacy interaction). National & Institutional legacy plans developed, building on the strengths of the GPEI (e.g. access) to benefit generations to come, including: Essential polio functions mainstreamed into ongoing national and institutional structures (e.g. immunization). Resources, lessons and knowledge documented and transitioned to other health priorities as appropriate. Goal: To ensure, that these are the outcomes of the Legacy Planning process, and that we all plan a rational future together.